CD80 and neoplasm: Another possible explanation is that PD‐L1 binds two receptors, PD‐1 and B7.1 (CD80), and B7.1 is a key co‐stimulatory molecule on tumor‐associated dendritic cells (DC) that enhances T‐cell initiation through B7.1/CD28 interaction [45].